Kinnate Biopharma is recruiting for patients with a BRAF mutation-positive cancers or NRAS mutation-positive melanoma who are in
21 Jun 2022, 15:06
Kinnate Biopharma is recruiting for patients with a BRAF mutation-positive cancers or NRAS mutation-positive melanoma who are interested in participating in a clinical trial.
Click below to learn more!
#cancer #genomictesting #educatedpatient #NRAS